Sage Therapeutics Inc (SAGE) - News Archive

Sage Therapeutics: Striking Acquisition Interest Amidst Unprecedented Revenue Surge In a significant development within the biopharmaceutical sector, Sage Therapeutics, Inc. confirmed it has received an unsolicited, non...

Sage Therapeutics, Inc. has recently reported findings from two pivotal clinical studies evaluating newer treatments for neurological conditions, particularly Alzheimer s disease and essential tremor. This article inter...

Sage Therapeutics, Inc. has announced the cessation of its collaboration with Biogen regarding the SAGE-324 program, a move that follows the recent unfavorable outcomes of the Phase 2 KINETIC 2 Study. This decision mark...

Rosen Law Firm Urges Sage Therapeutics, Inc. Investors to Act Before Securities Class Action Deadline In a significant reminder for investors, Rosen Law Firm, a prominent and trusted global investor rights law firm, has...

Sage Therapeutics: Advancing Brain Health Through Innovative Therapies and Strong Market Performance Sage Therapeutics, Inc. is at the forefront of transforming brain health through pioneering biopharmaceuticals targeti...

In a collaborative effort, Sage Therapeutics, Inc. and Biogen Inc. have recently disclosed the topline findings from the Phase 2 KINETIC 2 study evaluating the potential effectiveness of SAGE-324 (BIIB124) as a treatmen...

In recent news, Pomerantz LLP, a renowned law firm based in New York, has commenced an investigation on behalf of investors of Sage Therapeutics, Inc. (NASDAQ: SAGE), a leading biopharmaceutical company. This exploratio...

Sage Therapeutics to Participate in Upcoming Investor Conferences in MayCambridge, Mass. - Sage Therapeutics, a leading biopharmaceutical company focused on improving brain health, has confirmed its participation in two...

Sage Therapeutics Surges Ahead with Successful Launch of ZURZUVAE in First Quarter 2024CAMBRIDGE, Mass. - Sage Therapeutics, a biopharmaceutical company dedicated to revolutionizing brain health, has announced its impre...